Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.58 million shares were traded.
Ratios:
For a deeper understanding of Rani Therapeutics Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 14.93 whereas as Long-Term Debt/Eq ratio is at 6.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 02, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On June 14, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $15.
On June 13, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $10.Rodman & Renshaw initiated its Buy rating on June 13, 2024, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 13 ’24 when McKinley Kate bought 17,960 shares for $1.67 per share. The transaction valued at 29,993 led to the insider holds 17,960 shares of the business.
Imran Talat bought 10,296 shares of RANI for $19,974 on Dec 09 ’24. The Chief Executive Officer now owns 494,751 shares after completing the transaction at $1.94 per share. On Oct 15 ’24, another insider, South Cone Investments Limited, who serves as the 10% Owner of the company, sold 3,829,360 shares for $2.65 each. As a result, the insider received 10,141,674 and left with 8,302,194 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 62.57 while its Price-to-Book (P/B) ratio in mrq is 18.80.
Stock Price History:
Over the past 52 weeks, RANI has reached a high of $7.88, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is -20.29%, while the 200-Day Moving Average is calculated to be -44.78%.
Shares Statistics:
A total of 33.43M shares are outstanding, with a floating share count of 22.79M. Insiders hold about 32.12% of the company’s shares, while institutions hold 8.22% stake in the company.
